VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI), a Nevada corporation, today announced it will offer licenses in select markets for Diabetes Treatment Centers.
CARSON CITY, Nev. (Business Wire EON) April 24, 2008 --
VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI), a Nevada
corporation, today announced it will offer licenses in select markets
for Diabetes Treatment Centers.
The license will allow qualified professionals to administer the highly
successful iCAT Therapy to patients with Type 1 and Type 2 diabetes.
VitalCare will offer complete setup and training to all personnel at
each center with a comprehensive ongoing support program. Licenses will
also be offered to qualified medical groups and HMOs.
Jimmy McDougald, CEO of VitalCare, stated, “This
is a unique opportunity for all those in the medical field who really
want to make a difference in the lives of patients with Type 1 and Type
2 diabetes. The results of iCAT Therapy are well documented and speak
for themselves.”
About VitalCare Diabetes Treatment Centers, Inc.
VitalCare Diabetes Treatment Centers, Inc. is a company specializing in
providing Administrative, Marketing, Business Development, Strategic
Planning, Clinical Oversight and Clinical Management Services to the
Diabetes Healthcare Sector, with an emphasis in bringing "Cutting Edge"
medical devices and healthcare services direct to consumers, focusing on
an emerging FDA approved, US and European Patented technology and
treatment intervention for treating Type 1 and Type 2 Diabetes known as “Intracellular
Activation Therapy (iCAT).”
Safe Harbor Statement: Forward-looking statements in this release with
respect to VitalCare Diabetes Treatment Centers, Inc.’s
business, financial condition and results of operations, as well as
matters of timing and the prospective terms of the transaction described
are subject to risks and uncertainties that could cause actual results
to differ materially from those expressed in the forward-looking
statements, including, but not limited to, certain delays beyond
VitalCare Diabetes Treatment Centers, Inc.’s
control with respect to market acceptance of their technology and/or
products, whether financing will be available, the effect of the
application of acquisition accounting policies as well as certain other
risk factors which are and may be detailed from time to time in VitalCare’s
filings with the Securities and Exchange Commission.
Trackback URL: http://www.prweb.com/pingpr.php/U3VtbS1TaW5nLVNxdWEtTG92ZS1GYWx1LVplcm8=
|
